Project to promote UK life sciences sectors

3 December 2007

A new marketing strategy for promoting the UK's expertise in the biotechnology, pharmaceutical and health care sectors, which brings together the government and business, has been launched by the Minister of State for Trade and Investment, Lord Digby Jones. This includes individual marketing campaigns for each of the three sectors and setting up a marketing strategy board.

Introducing the move, Lord Jones said that, as "a global center of life science creativity, the UK punches well above its weight in these sector. In investment terms, we lead in Europe and are second only to the USA. The pharmaceutical industry alone contributed over L12.0 billion ($24.62 billion) to UK exports in 2006. But, to stay ahead, we need to exploit the opportunities that new technologies are offering. Global competition in the life science sectors is intense and growing, and we need to ensure we are among th first to make in-roads into emerging markets like China and India."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight